The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Isotopes for Nuclear Medicine Market Research Report 2025
Synopsis
Global Isotopes for Nuclear Medicine market is projected to reach US$ 11510 million in 2029, increasing from US$ 6595 million in 2022, with the CAGR of 8.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Isotopes for Nuclear Medicine market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Isotopes for Nuclear Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
NTP Radioisotopes
Medical Isotopes
ITM
Cambridge Isotope Laboratories
CMR
Urenco
Northwest Medical Isotopes
SHINE Medical
Segment by Type
Stable Isotope
Radioisotope
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Isotopes for Nuclear Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Isotopes for Nuclear Medicine market is projected to reach US$ 11510 million in 2029, increasing from US$ 6595 million in 2022, with the CAGR of 8.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Isotopes for Nuclear Medicine market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Isotopes for Nuclear Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
NTP Radioisotopes
Medical Isotopes
ITM
Cambridge Isotope Laboratories
CMR
Urenco
Northwest Medical Isotopes
SHINE Medical
Segment by Type
Stable Isotope
Radioisotope
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Isotopes for Nuclear Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isotopes for Nuclear Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stable Isotope
1.2.3 Radioisotope
1.3 Market by Application
1.3.1 Global Isotopes for Nuclear Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isotopes for Nuclear Medicine Market Perspective (2018-2029)
2.2 Isotopes for Nuclear Medicine Growth Trends by Region
2.2.1 Global Isotopes for Nuclear Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Isotopes for Nuclear Medicine Historic Market Size by Region (2018-2023)
2.2.3 Isotopes for Nuclear Medicine Forecasted Market Size by Region (2024-2029)
2.3 Isotopes for Nuclear Medicine Market Dynamics
2.3.1 Isotopes for Nuclear Medicine Industry Trends
2.3.2 Isotopes for Nuclear Medicine Market Drivers
2.3.3 Isotopes for Nuclear Medicine Market Challenges
2.3.4 Isotopes for Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Isotopes for Nuclear Medicine Players by Revenue
3.1.1 Global Top Isotopes for Nuclear Medicine Players by Revenue (2018-2023)
3.1.2 Global Isotopes for Nuclear Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Isotopes for Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Isotopes for Nuclear Medicine Revenue
3.4 Global Isotopes for Nuclear Medicine Market Concentration Ratio
3.4.1 Global Isotopes for Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isotopes for Nuclear Medicine Revenue in 2022
3.5 Isotopes for Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Isotopes for Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Isotopes for Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Isotopes for Nuclear Medicine Breakdown Data by Type
4.1 Global Isotopes for Nuclear Medicine Historic Market Size by Type (2018-2023)
4.2 Global Isotopes for Nuclear Medicine Forecasted Market Size by Type (2024-2029)
5 Isotopes for Nuclear Medicine Breakdown Data by Application
5.1 Global Isotopes for Nuclear Medicine Historic Market Size by Application (2018-2023)
5.2 Global Isotopes for Nuclear Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Isotopes for Nuclear Medicine Market Size (2018-2029)
6.2 North America Isotopes for Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Isotopes for Nuclear Medicine Market Size by Country (2018-2023)
6.4 North America Isotopes for Nuclear Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Isotopes for Nuclear Medicine Market Size (2018-2029)
7.2 Europe Isotopes for Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Isotopes for Nuclear Medicine Market Size by Country (2018-2023)
7.4 Europe Isotopes for Nuclear Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Isotopes for Nuclear Medicine Market Size (2018-2029)
8.2 Asia-Pacific Isotopes for Nuclear Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Isotopes for Nuclear Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Isotopes for Nuclear Medicine Market Size (2018-2029)
9.2 Latin America Isotopes for Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Isotopes for Nuclear Medicine Market Size by Country (2018-2023)
9.4 Latin America Isotopes for Nuclear Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Isotopes for Nuclear Medicine Market Size (2018-2029)
10.2 Middle East & Africa Isotopes for Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NTP Radioisotopes
11.1.1 NTP Radioisotopes Company Detail
11.1.2 NTP Radioisotopes Business Overview
11.1.3 NTP Radioisotopes Isotopes for Nuclear Medicine Introduction
11.1.4 NTP Radioisotopes Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.1.5 NTP Radioisotopes Recent Development
11.2 Medical Isotopes
11.2.1 Medical Isotopes Company Detail
11.2.2 Medical Isotopes Business Overview
11.2.3 Medical Isotopes Isotopes for Nuclear Medicine Introduction
11.2.4 Medical Isotopes Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.2.5 Medical Isotopes Recent Development
11.3 ITM
11.3.1 ITM Company Detail
11.3.2 ITM Business Overview
11.3.3 ITM Isotopes for Nuclear Medicine Introduction
11.3.4 ITM Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.3.5 ITM Recent Development
11.4 Cambridge Isotope Laboratories
11.4.1 Cambridge Isotope Laboratories Company Detail
11.4.2 Cambridge Isotope Laboratories Business Overview
11.4.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Introduction
11.4.4 Cambridge Isotope Laboratories Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.4.5 Cambridge Isotope Laboratories Recent Development
11.5 CMR
11.5.1 CMR Company Detail
11.5.2 CMR Business Overview
11.5.3 CMR Isotopes for Nuclear Medicine Introduction
11.5.4 CMR Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.5.5 CMR Recent Development
11.6 Urenco
11.6.1 Urenco Company Detail
11.6.2 Urenco Business Overview
11.6.3 Urenco Isotopes for Nuclear Medicine Introduction
11.6.4 Urenco Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.6.5 Urenco Recent Development
11.7 Northwest Medical Isotopes
11.7.1 Northwest Medical Isotopes Company Detail
11.7.2 Northwest Medical Isotopes Business Overview
11.7.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Introduction
11.7.4 Northwest Medical Isotopes Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.7.5 Northwest Medical Isotopes Recent Development
11.8 SHINE Medical
11.8.1 SHINE Medical Company Detail
11.8.2 SHINE Medical Business Overview
11.8.3 SHINE Medical Isotopes for Nuclear Medicine Introduction
11.8.4 SHINE Medical Revenue in Isotopes for Nuclear Medicine Business (2018-2023)
11.8.5 SHINE Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
